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Background: The ciliary body epithelia (CBE) of the eye produce the aqueous humor (AH). The equilibrium
between the AH production by the CBE and the outflow through the trabecular meshwork ultimately determines
the intraocular pressure (IOP). An increased IOP is a major risk factor for primary open angle glaucoma (POAG). This
study aims to elucidate the molecular machinery of the most important function of the CBE: the AH production
and composition, and aims to find possible new molecular clues for POAG and AH production-lowering drugs.
Methods: We performed a gene expression analysis of the non-pigmented (NPE) and pigmented epithelia (PE) of
the human CBE of post mortem eyes. We used 44 k Agilent microarrays against a common reference design.
Functional annotations were performed with the Ingenuity knowledge database.
Results: We built a molecular model of AH production by combining previously published physiological data with
our current genomic expression data. Next, we investigated molecular CBE transport features which might influence
AH composition. These features included caveolin- and clathrin vesicle-mediated transport of large biomolecules, as
well as a range of substrate specific transporters. The presence of these transporters implies that, for example,
immunoglobins, thyroid hormone, prostaglandins, cholesterol and vitamins can be secreted by the CBE along with
the AH. In silico, we predicted some of the molecular apical interactions between the NPE and PE, the side where
the two folded epithelia face each other. Finally, we found high expression of seven POAG disease genes in the
plasma membrane of extracellular space of the CBE, namely APOE, CAV1, COL8A2, EDNRA, FBN1, RFTN1 and TLR4 and
we found possible new targets for AH lowering drugs in the AH.
Conclusions: The CBE expresses many transporters, which account for AH production and/or composition. Some of
these entries have also been associated with POAG. We hypothesize that the CBE may play a more prominent role
than currently thought in the pathogenesis of POAG, for example by changing the composition of AH.
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The ciliary body epithelia (CBE) in the eye, consisting of
the non-pigmented (NPE) and pigmented epithelia (PE),
are responsible for the production of the aqueous humor
(AH). This production includes passive diffusion, active
transport and production of molecules from the CBE into* Correspondence: a.bergen@nin.knaw.nl
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stated.the AH. Via the anterior chamber, the AH exits the eye
trough the trabecular meshwork (TM) and the canal of
Schlemm into the venous blood system. The balance
between the production and outflow of AH ultimately
determines the intraocular pressure (IOP).
In many physiological in vitro and in vivo animal studies,
the major ion-channel and transporter proteins involved
in AH production have already been identified. In short,
the chain of events leading to AH production starts with
the PE cells that actively take up ions at their stromal
(basolateral) surface (major channels Na+-K+-2Cl- sympor-
ters, Cl--HCO3
- and Na+-H+ antiporters, K+ channels).l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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the PE and NPE cell. The NPE cells actively secrete ions
into the AH (major channels Na+-K+-activated ATPase,
H+-ATPase, Na+-K+-2Cl- symport, K+ and Cl- channels).
Water follows by passive diffusion through water channels
(aquaporins). Together, the studies on ion-channels led to
a physiological model of AH production in the CBE
(reviewed in [1,2]). However, the specific genes that code
for these ion channels are still unknown for many of these
channels. The first aim of our current study was to investi-
gate the human molecular background of the physiological
AH production model.
Besides the ion-channels directly involved in AH pro-
duction, the CBE expresses also other transporters [3,4].
These transporters may play a role in the composition of
the AH, which determines a range of other functionalities
previously assigned to the CBE. These are, for example,
nourishment of avascular tissues in the eye (lens, cornea),
neuro-endocrine signaling to the TM and other tissues
and maintenance of the immune privilege of the eye. Our
second aim of this study was to investigate the genetic
identity of these transporters in the CBE.
The NPE and PE are folded, polarized neuroepithelial
cell layers that face each other at their apical sides. At this
side of the NPE and PE, secreted and plasma membrane bio-
molecules of both epithelia can interact. These biomolecules
include signaling molecules, growth factors and extracellular
matrix molecules. We are interested in the molecular charac-
teristics of this apical interaction between NPE and PE.
In disease state, like primary open angle glaucoma
(POAG), AH composition may be disturbed [5-7]. POAG
is a neurodegenerative disease characterized by abnormal
cupping of the optic nerve head and corresponding visual
field defects that cannot be explained by other diseases,
and with a normal open anterior chamber of the eye [8].
A major risk factor for POAG is an increased intraocular
pressure (IOP) [9,10]. Proteomic analysis of POAG AH
showed an increased level of total protein content and also
the presence of larger and potentially harmful molecules
compared to control AH [5-7]. This changed AH compos-
ition in POAG may ultimately affect the outflow facility of
the TM via intrinsic molecular and structural changes,
which will result in a decreased outflow and an increased
IOP. The fourth aim of our study was to look for expression
of POAG disease genes in the CBE, and we hypothesize
about their potential role in the CBE in POAG when these
genes are mutated.
The only proven therapy of POAG is lowering of the
IOP. Drugs that lower the IOP target the CBE to decrease
AH production or target the TM to increase AH outflow.
With our newly formed hypothetical molecular model of
AH production in the CBE (first aim of this study), we
finally looked for potentially new targets to change the
AH production with already existing drugs.Methods
Ethics statement
This study was performed in agreement with the declar-
ation of Helsinki on the use of human material for research.
The human post-mortem donor eyes were obtained from
the Corneabank, Beverwijk, the Netherlands. The Cornea-
bank obtained permission (informed consent) from the
donors for enucleation of the eyes and to use the eye for
scientific purposes after removal of the cornea. All data
were analyzed anonymously.
Tissue sampling, RNA processing and microarray
We performed gene expression analysis on separately laser
dissected NPE (n = 7) and PE (n = 7) cells (only pars plicata
of the CBE) with microarray studies. For detailed descrip-
tion of donor eye selection, tissue sampling, RNA process-
ing and microarray performance, we refer to our previously
published paper [11]. In short, we selected seven healthy
human donor eyes that were snap frozen. From 20 μm
cryosections, the NPE and PE were separately cut out
with laser dissection microscopy (PALM Carl Zeiss,
Microlaser Technologies AG, Germany). Cresyl Violet
staining was used to distinguish NPE (Merck, Frankfurt,
Germany, art.5235). After selection of NPE and PE cells,
RNA was isolated, amplified and labeled. Microarrays were
performed against common reference sample (RPE/choroid
RNA), in order to compare NPE and PE and normalize the
data. The total gene expression datasets can be found in
Gene Expression Omnibus database (GSE37957).
Data analysis I: construction of sub-datasets
From the gene expression studies on the (N)PE, we ranked
the genes by expression level and assigned percentile ranks
(P) [12]. Next, we formed four sub-datasets: high expres-
sion (expression >90th P), moderate expression (50-90th P),
low expression (10-50th P) and very low expression (<10th P).
This means, for example, that a gene in the high expres-
sion sub-dataset has an expression intensity that falls into
the highest 10% intensity values of the microarray. We
also performed a statistical comparison between NPE
and PE and stated gene expression statistically significant
different between NPE and PE when p-value < 0.01 (cor-
rection for multiple testing; Significant Different sub-
dataset). Finally, we determined the signature genes of
NPE and PE, based on the selection criteria of fold-change
>2.5 and p-value < 0.01 between NPE and PE.
From these different gene expression analyses, we studied
the molecular background of AH production. In previous
functional and physiological studies of in vitro and in vivo
animal models of the CBE, ion channels that are involved
in the AH production were widely studied. In a review of
Civan and coworkers [2], these findings are put together
in a model of AH production. We now looked for the
gene expression level (high, moderate, low and very low)
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checked whether genes were a signature gene for one epi-
thelial layer. We listed all the gene expression information
of these ion-channel coding genes in Additional file 1:
Table S1 and in Table 1 we presented genes with moderate
or high expression level in at least one epithelial layer.
Data analysis II: molecular machinery of AH production,
CBE transport and (N)PE interaction
We further studied the molecular machinery of AH
production, CBE transport and interaction of NPE and
PE. We therefore created new sub-datasets. First, we com-
bined the genes from the Highly Expressed NPE and PE
sub-datasets (>90th P) and the genes from the Significantly
Different sub-dataset (with mean gene expression value
higher than 50th percentile), since we assumed that at least
these genes are of biological importance for the (N)PE
[12,13]. We took all Significantly Different expressed
genes together, so without subdivision between NPE
and PE, since it is difficult to attribute specific biological
meaning in a set of up- or down regulated genes, without a
base-line, to one of two specific (N)PE layers that are both
healthy and from the same person (p-value<0.01 and fold-
change >2.5). Still, we believe that these differences, without
attributing them to a specific epithelial layer, are of bio-
logical meaning. We therefore choose to include the highly
and significant different expressed genes together for future
analysis. The cell specific genes were determined with
much more strict criteria and stated as signature genes.
The signature genes were than specifically attributed to PE
or NPE. This approach was also previously used [11]. From
this pool we selected those genes that coded, according to
the Ingenuity knowledge database, for either plasma mem-
brane or extracellular secreted proteins. Obviously, the en-
tries from this selection are most likely to be involved in
transmembrane transport mechanisms and interactions
between two cell types compared with genes localized in
the cytoplasm or nucleus. We named this new dataset,
which contained highly expressed genes in the plasma
membrane or extracellular space of the CBE, the Trans-
port sub-dataset (flow diagram in Figure 1) (total Trans-
port sub-dataset in Additional file 2: Table S2).
Data analysis III: detailed analysis of the transport
sub-dataset
We analyzed the Transport sub-dataset from five different
points of view:
1) In silico hypothetical molecular model of the AH
production: We translated the model of AH
production from Civan and coworkers [2] into a
hypothetical in silico molecular model of AH
production based on our Transport sub-dataset. We
specifically indicated the signature genes in the figure.2) Transport mechanisms in the neuro-epithelia of the
CBE: We studied all transporters and ion channels
present in the Transport sub-dataset to infer
possible specialized transport functions of the CBE.
The signature genes of NPE or PE were specifically
indicated. For conformation, we performed
immunohistochemistry of two proteins of interest,
caveolin-1 (CAV1) and clathrin heavy chain (CLTR).
The methods of immunohistochemistry were
described in detail elsewhere [11]. We used primary
antibodies of Abcam (Cambridge, UK), for CAV1 a
rabbit polyclonal (ab2910) and for CLTR also a
rabbit polyclonal (ab21679).
3) Apical PE-NPE interaction and transport
mechanisms: In order to study the possible
molecular interaction PE and NPE, we selected from
the Transport sub-dataset those genes which
encoded proteins that are apically present in the
plasma membrane or apically secreted into the
extracellular space. We derived the protein
localizations from the Ingenuity knowledge database
and from Pubmed. We used the search term ‘gene
name AND (apical OR basolateral OR subcellular
location OR immuno location)’. We formed two
new sub-datasets, named the Apical Plasma
Membrane sub-dataset and Apical Extracellular
secreted sub-dataset (flow-diagram in Figure 1).
With these two newly formed sub-datasets, we
analyzed functional interaction by exploring possible
direct connections between the entries using
Ingenuity’s tool ‘Connect’, resulting in two functional
molecular networks. The first one indicating the
functional interaction between apical secreted
molecules in the extracellular space between NPE
and PE and the second one indicating the transport
molecules in the apical plasma membrane that are
connected to the apical secreted molecules from the
former network. Entries connected to themselves have
a circle on top; entries that did not have a connection
with another gene were removed (detailed description
of Ingenuity see www.ingenuity.com and [11]). Yellow
symbols indicate PE signature genes.
4) CBE transport and possible implications for POAG:
Based on the list of (candidate) POAG disease genes
that we recently selected (reviewed by [14]), we
looked in our Transport sub-dataset for presence of
these (candidate) POAG disease genes.
5) Possible pharmacological targets for AH production
altering drugs within the CBE. Within the Transport
sub-dataset we looked for genes that code for
targets of known AH production lowering drugs.
We also looked in the hypothetical molecular model
for AH production that we built (first aim) for drugs
that target on proteins in this model. These drugs
Table 1 Human CBE gene expression profiles for ion
channels implicated in AH production
Ion channel Gene name NPE PE SIG
Water channel AQP1* H H
AQP2 M M
AQP5 L M
AQP11* M M
Na+/K+ ATPase ATP1A1* H H
ATP1A2* H H
ATP1A3 M M
ATP1A4 M M
ATP1B1* H H PE
ATP1B2* H H
ATP1B3* H H
Cl- channel CLCN2 L M
CLCN3 M M
CLCN6 M M
CLCN7 M M
CLIC1* H H
CLIC2 L M
CLIC4* H H
CLIC6* M H
Gap junction GJA1* H H
GJA4* M M PE
K+ channel KCNA5* L M
KCNAB1 M M
KCNB1 M M
KCNB2* L M PE
KCND2* L M PE
KCND3* M M
KCNE1 M M
KCNE3 H M
KCNE4 L M
KCNG1 M M
KCNJ12 M M
KCNJ13* H H
KCNJ14 M M
KCNJ2 M M
KCNJ8* M M
KCNK1 M M
KCNK13 M M
KCNK15 M M
KCNK3 M L
KCNK4 L M
KCNK7 M M
KCNQ1* M M
Table 1 Human CBE gene expression profiles for ion
channels implicated in AH production (Continued)
KCNS3* M M
KCNV2 M M
Na+ channel SCN2B M M
SCN3B M M
SCN4B* H H
Na+/2Cl-/K+ co-transport SLC12A2 M M
Cl-/HCO3- exchanger SLC4A2* L M
SLC4A3 M M
Na+/HCO3- symport SLC4A4 M M
SLC4A7 M M
Na+/H+ exchanger SLC9A5 M M
SLC9A6 M L
SLC9A9 M M
Expression profiles of genes coding for ion channels implicated in aqueous
humor (AH) production in healthy human non-pigmented (NPE) or pigmented
epithelium (PE) of the ciliary body. The list of ion-channels involved in AH
production is from Civan et al., 2004. We ranked the genes by expression level
and assigned percentile ranks (P). Next, we formed four groups: high (H)
expression (expression >90th P), moderate (M) expression (50-90th P), low (L)
expression (10-50th P) and very low (VL) expression (<10th P). We also
compared the NPE and PE expression data and indicated if genes were
signature genes (SIG) of an epithelial cell layer (p-value < 0.01 and fold change
>2.5). In this table, we only presented genes with moderate or high expression
level in at least one epithelial layer. The total list of ion-channels and gene
expression profiles is presented in Additional file 1: Table S1. Genes indicated
with * are also present in Transport sub-dataset and indicated in Figure 2.
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strategies to alter/decreased AH production.Results
1. In silico hypothetical molecular model of the AH
production
Twenty four highly expressed genes in our Transport
sub-dataset coded for ion-channels involved in AH pro-
duction. Furthermore, 32 additional ion-channel coding
genes were moderately expressed in the NPE and/or PE
(Table 1). Of all these genes, four were signature genes
of the PE compared the NPE, namely ATP1B1, GJA4,
KCNB2, and KCND2. We translated the model of AH
production of Civan and coworkers [2] into a hypothetical
molecular model of AH production in which we included
the genes of the Transport sub-dataset (Figure 2).2. Transport mechanisms in the neuro-epithelia of the CBE
To determine which CBE highly expressed genes could
ultimately be involved in the composition of the AH, we
assessed the expression of all transporters and (cat-)ion
channels and their specific substrate in the Transport
sub-dataset. Total list is outlined in Table 2. Different
groups of transporters can be distinguished.
Figure 1 Flow diagram. Schematic overview of the subdivisions made in the gene expression data of the NPE and PE into different sub-datasets.
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caveolin and clathrin
We identified many different entries in our Transport
sub-dataset involved in endo- and exocytosis as well as
vesicle mediated transport (ANXA2, -4, -5, -7, CAV1, CLTA,Figure 2 Hypothetical molecular model of aqueous humor productio
production of Civan and coworkers [2]. This model includes the different io
hypothetical in silico molecular model of AH production. This model is base
our strict selection criteria of the 10% highest and significant different expr
(all together in the Transport sub-dataset; see Methods). For the Na+/K+/2Cl
coding gene in the Transport sub-dataset (indicated with * in the model). G
example SLC12A2) can be found in Table 1. The underlined genes (ATP1B1,
NPE (fold change >2.5 and p-value < 0.01; see Methods section).CLTC, EXOC7, SORL1, STXBP3, SV2B, SYPL1, SYT13,
VAT1, and VTI1B).
Using immunohistochemistry, we confirmed the presence
of caveolin-1 (CAV1) and clathrin heavy chain proteins
(CLTR) in the CBE (Figure 3). More specifically, we foundn. On the left, there is the physiological model of aqueous humor (AH)
n-channels involved in the AH production. On the right, there is
d on our gene expression data of the ciliary body epithelia (CBE) and
essed genes of the non-pigmented (NPE) and pigmented epithelia (PE)
- symporter (coded by SLC12A1 and SLC12A2) we did not found a
enes coding for ion-channels with moderate expression levels (for
GJA4, KCNB2, KCND2) are signature genes of the PE compared to the
Table 2 All transporters in the Transport sub-dataset of the ciliary body epithelia
Symbol ID Symbol ID Symbol ID
A2M NM_000014 GJA4a NM_002060 SLC22A4 NM_003059
ABCA1a NM_005502 GPIHBP1 NM_178172 SLC22A5 NM_003060
ABCA4 NM_000350 GPM6A NM_201591 SLC23A2a NM_203327
ABCA5 NM_018672 GRIN2C NM_000835 SLC24A3 NM_020689
ABCA7 NM_019112 GRIN3A NM_133445 SLC26A7a NM_052832
ABCB1 NM_000927 HCN2 NM_001194 SLC27A1 NM_198580
ABCC1a NM_019862 HEPH NM_014799 SLC29A4 NM_001040661
ABCC5 NM_005688 IGFBP7 NM_001553 SLC2A1 NM_006516
ABCC9 NM_020297 ITGAVa NM_002210 SLC2A4 NM_001042
ABCG2 NM_004827 KCNA5 NM_002234 SLC31A2 NM_001860
ANO2 NM_020373 KCNB2a NM_004770 SLC35G1 NM_153226
ANO6 NM_001025356 KCND2a NM_012281 SLC38A1 NM_030674
ANXA2 NM_001002857 KCND3 ENST00000369697 SLC38A2 NM_018976
ANXA4 NM_001153 KCNJ13 NM_002242 SLC38A9 NM_173514
ANXA5 NM_001154 KCNJ8 NM_004982 SLC39A14 NM_015359
ANXA7 NM_004034 KCNMB4 NM_014505 SLC39A8 NM_022154
APOE NM_000041 KCNQ1 NM_000218 SLC3A2 NM_001012661
AQP1 NM_198098 KCNS3 NM_002252 SLC40A1a NM_014585
AQP11 NM_173039 LDLR NM_000527 SLC43A3 NM_199329
ATP13A1 NM_020410 MAL NM_002371 SLC45A2 NM_016180
ATP13A3 ENST00000310773 NRXN3 NM_004796 SLC4A4 NM_003759
ATP1A1 NM_000701 ORAI1 NM_032790 SLC5A6 NM_021095
ATP1A2 NM_000702 PDPN NM_006474 SLC6A13 BC020867
ATP1B1a NM_001677 PKD2 NM_000297 SLC6A15a NM_182767
ATP1B2 NM_001678 RAMP1a NM_005855 SLC6A20 NM_020208
ATP1B3 NM_001679 RBP1 NM_002899 SLC7A5 NM_003486
ATP2B3 NM_021949 RBP4 NM_006744 SLC7A7 NM_003982
ATP2B4 NM_001001396 REEP5 NM_005669 SLC7A8 NM_182728
ATP9A NM_006045 SCARB1 NM_005505 SLC9A3R1 NM_004252
BEST1 NM_004183 SCN4B NM_174934 SLC9A6 NM_001042537
CACNA1C NM_000719 SCN8A AK091315 SORL1 NM_003105
CAV1 NM_001753 SERINC1 NM_020755 STXBP3 NM_007269
CDH23 NM_022124 SLC12A4 NM_005072 SV2B NM_014848
CLIC4 NM_013943 SLC12A7 NM_006598 SYPL1 NM_182715
CLIC6 NM_053277 SLC13A3 NM_001011554 SYT13 NM_020826
CLNS1A NM_001293 SLC13A4 NM_012450 TF NM_001063
CLTA NM_007096 SLC16A2 NM_006517 TM9SF2 NM_004800
CLTC NM_004859 SLC16A3 NM_001042422 TNFAIP1 NM_021137
CNGB3 NM_019098 SLC16A6 NM_004694 TPCN1 AB032995
ECM1 NM_004425 SLC19A2 NM_006996 TRAK2 NM_015049
EXOC7 NM_001013839 SLC1A3 NM_004172 TRPM1 NM_002420
FOLR1 NM_016725 SLC1A4 NM_003038 TRPM3 NM_206948
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Table 2 All transporters in the Transport sub-dataset of the ciliary body epithelia (Continued)
FXYD6a NM_022003 SLC1A7 NM_006671 TTR NM_000371
GABRR1 NM_002042 SLC20A1 NM_005415 VAT1 NM_006373
GJA1 NM_000165 SLC20A2 NM_006749 VTI1B NM_006370
Legend: Transport sub-dataset of the CBE contains all NPE and PE highly expressed and significantly different expressed genes, whose protein
products are located in the plasma membrane or secreted in the extracellular space. Genes indicated with a are signature genes of the PE. We did
not identify signature genes of the NPE that code for transporters. Abbreviations of gene names are according to standard abbreviations used
in Genbank.
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ing in the PE. Furthermore, we observed strong staining of
CLTR in both the NPE and PE of the CBE, especially in the
apical plasma membrane.
Specific transporter activity in CBE: hormones, vitamins,
metabolism, metal ions
We found a number of genes coding for neuro-endocrine
transporters, like glutamate transporters (SLC1A3, SLC1A4,
SLC1A7), glutamate-gated ion channels (GRIN2C, GRIN3A),
GABA transporter (SLC6A13) and transporters of thyroid
hormone (SLC16A2, TTR), thiamine (SLC19A2), vitamin C
(SLC23A2; signature gene of PE), lipids (SLC27A1, APOE,
LDLR, SORL1, and SCARB1) and glucose (SLC2A1,
SLC2A4). We also identified genes coding for transporters
of zinc (SLC39A14, SLC39A8), copper (SLC31A2) and iron
(SLC40A1 (signature gene of PE), TF, HEPH) in the Trans-
port sub-dataset.Figure 3 Immunohistochemistry of caveolin 1 and clathrin in the cilia
clathrin (CLTR) in human ciliary body sections. Our gene expression data sh
(p-value < 0.01), with higher expression in NPE and all CLTR coding genes (
PE. In this immunofluorescence picture, CAV1 is clearly present in the non-
epithelium (PE). We found CLTR in both NPE and PE, especially in the apica
endothelium of the stroma. Negative controls were for both proteins nega
of interest.Transporter activity in CBE: organic anions and ions
(other than in the hypothetical molecular model of AH
production)
We identified high expression of several genes coding
for ABC transporters (ABCA1, ABCA4, ABCA5, ABCA7,
ABCB1, ABCC1, ABCC5, ABCC9 and ABCG2), respon-
sible for organic anion transport. ABCA1 and ABCC1 are
signature genes of the PE when compared to the NPE.
Moreover, we found genes coding for phosphate trans-
porters (SLC20A1, SLC20A2), carnitine transporters
(SLC22A4, SLC22A5), and amino acid transporters
(SLC38A1, SLC6A15 (signature gene of PE), SCL7A5,
SLC7A7, SLC7A8). Next, we found genes coding for other
ATP-transporters than that were already attributed for the
AH production, namely ATP2B3, ATP2B4, ATP13A1, -3,
and ATP9A, and genes coding for K+/Cl- transporters
(SLC12A4, SLC12A7) and the Na+/K+/Ca2+ exchanger
(SLC26A7, signature gene of PE).ry body. Immunofluorescence staining for caveolin 1 (CAV1) and
ow that CAV1 is significantly different expressed between NPE and PE
CLTA, CLTB and CLTC) are highly (>90th P) expressed in both NPE and
pigmented epithelium (NPE) and possibly also in the pigmented
l plasma membrane. Both CAV1 and CLTR were found in the vascular
tive (not shown). Legend: blue = dapi = cell nucleus; red = cy3 = protein
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Molecular interactions in the extracellular space between
the (N)PE apical sides
We explored the potential functional relationships between
the predicted secreted entries of the Apical Extracellular
Secreted sub-dataset (Figure 4). This network represents
potential molecular interactions taking place in the extra-
cellular space between the NPE and PE. The top functions
assigned to this network by Ingenuity were “Neurological
disease, psychological disorders and cellular movement”.
The network contained 34 genes of a total of 67 (51%)
secreted genes in the (N)PE apical extracellular space.
Interestingly, this network contained many entries in-
volved in matrix assembly and cytoskeleton organization
(COL18A1, CTGF, DCN, FBN1, FBLN1, LTBP1, SPARC,
and SPP1). Indeed, these proteins may partly fill the extra-
cellular space between the apical membranes of the NPE
and PE, as was previously shown for FBN1 by Gabriel and
coworkers [15]. We also found genes coding forFigure 4 Molecular interactions in the apical extracellular space of th
network build in Ingenuity (www.Ingenuity.com), representing entries that
between NPE and PE. The top functions assigned to this network by Ingen
movement”. This network is contains many entries involved in matrix assem
LTBP1, SPARC, and SPP1) and molecules involved in growth and proliferation
a signature gene of the PE (yellow symbol). Together, these molecules are
NPE layers of the CBE. We also identified several entries within the PE-NPE
metabolism and plaque formation (A2M, APOE, CLU, SERPINA3, and TTR). Le
entries with itself. Solid lines indicate that binding of the two proteins occu
activity of the second protein.components of the classical complement cascade (C1R,
C1S, C3, and CFB), the coagulation pathway (F10, PLAT
and PROS1) and immune and/or inflammatory responses
(CCL2 and IL6) and we identified many genes coding for a
range of growth factors (CTGF, EGF, IGF1, IGF2, IGFBP2-6,
LTBP1, PTN, TGFB2 and VEGFA). Finally, we identified
several entries apparently involved in amyloid beta metab-
olism and plaque formation (A2M, APOE, CLU, SERPINA3,
and TTR).
Molecular interactions in apical transport of the CB
We were interested in the transport mechanisms of the
entries in the apical extracellular space of the NPE and
PE. Therefore, we explored in silico potential functional
relationships between the genes coding for transporters in
the Apical Plasma Membrane sub-dataset and the network
described above. The resulting network is displayed in
Figure 5. The top functions assigned by Ingenuity to
this network were “Neurological disease, psychologicale pigmented (PE) and non-pigmented epithelium (NPE). Molecular
are highly expressed and secreted in the apical extracellular space
uity were “Neurological disease, psychological disorders and cellular
bly and cytoskeleton organization (COL18A1, CTGF, DCN, FBN1, FBLN1,
(CTGF, EGF, IGF1, IGF2, IGFBP2-6, LTBP1, PTN, TGFB2 and VEGFA). IGF1 is
likely to be involved in the local turnover of the ECM between the PE-
apical extracellular space of the CBE that are involved in amyloid-beta
gend of different lines: Circles on top indicate direct relationships of
r, arrows indicate that the first protein interfere with the expression or
Figure 5 Molecular interactions in apical transport of the ciliary body epithelia. Molecular network build in Ingenuity (www.Ingenuity.com),
representing possible transporters in the apical plasma membranes of the pigmented and non-pigmented epithelia that transport the apical
extracellular excreted entries outlined in Figure 4. The top functions assigned by Ingenuity to this network were “Neurological disease,
psychological disorders and cell-to-cell signaling and interaction”. The major transport mechanisms to which these genes were connected were
vesicle-mediated transporters (ANXA7, CAV1, CLTA, CLTC, and SORL1) and lipid (ABCA1, LDLR and SCARB1) and xenobiotic (ABCC5 and ABCG2)
transporters. Two PE signature genes, ABCA1 and SLC40A1 (yellow symbols) are involved in this network. Legends of different lines: see Figure 4.
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network showed direct interactions of 15 transporter genes
(from a total of 50 genes; 30%) in the apical plasma
membrane with the apical extracellular secreted molecules.
Clearly, several entries involved in vesicle-mediated trans-
port were connected to the extracellular secreted entries,
namely ANXA7, CAV1, CLTA, CLTC, and SORL1. Further-
more, we identified several genes in the apical plasma mem-
brane that codes for proteins involved in lipid transport
(ABCA1 (signature gene of PE), LDLR and SCARB1), iron
transport (SLC40A1; signature gene of PE) and xenobiotic/
drug transport (ABCC5 and ABCG2) that are connected
to molecules in the apical extracellular space of the CBE.
4. CBE transport and possible implications for POAG
In our Transport sub-dataset we found seven genes that
were previously associated with POAG, namely APOE,
CAV1, COL8A2, EDNRA, FBN1, RFTN1 and TLR4. None
of these genes were signature genes of the NPE or PE.5. Possible pharmacological targets for AH production
altering drugs within the CBE
The three classes of drugs that can lower AH production
are adrenergic agonists, carbonic anhydrase (CA) inhibitors
and beta blockers. Within our Transport sub-dataset we
found high expression of CA4 and CA14 in the plasma
membrane of the CBE.
We also looked closer to the ion-channels in the hypo-
thetical model of AH production (Figure 2) for poten-
tially new drugs that might target these channels. For the
Na+/K + ATPase (coded by ATP1A1 and ATP1A2) there
are several inhibitors, namely digoxin, omeprazole, etha-
crynic acid and perphenazine. Two sodium channels coded
by SCN4B and SCN8A genes are inhibited by riluzole, a
drug used in ALS. Finally, the potassium channels coded
by KCNA5 and KCNQ1 can be blocked by quinidine, ami-
odarone, tedisamil and flecainide (antianginal and antiar-
rhythmic drugs) or opened by nicorandil (frequently used
against hypertension).
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In order to shed light on the molecular mechanisms in
the CBE related to AH production and composition, we
analyzed our expression data of the NPE and PE from
five different angles. First, we studied the expression
profiles of the genes coding for all ion-channels involved
in AH production and we built in silico a hypothetical
molecular model for AH production. Next, we assessed
putative transport mechanisms in the NPE and PE, in-
cluding vesicle mediated and specialized transport. Third,
we analyzed, in silico, several apical molecular networks
present between the NPE and PE, amongst others with
respect to transport and extracellular matrix molecules.
Fourth, we identified a number of clues which suggest that
the CBE plays an important (transport) role in POAG. And
finally, we looked for existing and possible new pharmaco-
logical targets in the CBE which could potentially modify
the AH production.
Our microarray approach and corresponding functional
annotations have several limitations, which are extensively
discussed elsewhere [12,13]. The gene expression datasets
used in the current study were first roughly analyzed in a
previous paper, which describes the general properties of
the CBE [11]. The value of the current study is that we
now analyzed these datasets in detail, primarily focused on
the molecular machinery underlying transport mechanisms.
Fortunately, the physiology of the transport mechanisms in
the CBE has previously already been studied extensively
in in vitro and in vivo models, and was leading for our
molecular analysis and interpretation.
Obviously, the amount of (combination of old and)
new data presented in this manuscript prohibits verification
in vitro and in vivo models in one single study, let alone in
this manuscript.
Finally, it must be taken into account that we used
very strict selection criteria for our Transport sub-
dataset. Therefore, the genes that we selected for fur-
ther future analysis in this manuscript may not cover
all genes that are involved in the transport and AH
production functions of the CBE. It is not unlikely that
there is functional redundancy, and that several similar
genes may code for more or less effective additional
transport proteins, or that more – yet to be identified –
proteins may be involved in AH production. On the other
hand, because of our strict selection criteria, the genes that
are present in this model, are likely to be truly involved
in the molecular machinery of AH production and CBE
transport mechanisms.1. In silico hypothetical molecular model of the AH
production
We build a hypothetical molecular model of AH produc-
tion based on the gene expression data of (the ion-channelsin) the CBE (Figure 2). We selected genes under strict
selection criteria in the Transport sub-dataset.
Due to these strict selection criteria, a number of
additional genes or proteins, previously implicated in AH
production, did not pop up in our present hypothetical
molecular model (Figure 2). For example, for the
Na+/K+/2Cl- symporter (coded by SLC12A1 or SLC12A2)
we did not found a coding gene in our Transport sub-
dataset, but these genes were moderately (SLC12A2) and
lowly (SLC12A1) expressed in the (N)PE (Table 1).
2. Transport mechanisms in the neuro-epithelia of the CBE
The CBE expresses many genes coding for ion-channels
and transporters at high levels. Due to their known sub-
strate specificity of their corresponding proteins, we can
also predict the biomolecules transported by these CBE
entries. Consequently, our inventory, in combination with
data from the literature, showed that the CBE most likely
transports a wide variety of molecules, including cations,
organic cations and anions, amino acids, glutamate,
GABA, iron, copper, zinc, thyroid hormone, vitamin A,
B and C, glucose, and fatty acids. Indeed, the majority
of these ions and biomolecules were also found in pre-
vious proteomic studies of the AH, which suggests that
the CBE is an important ocular entry point of these
molecules [16-20].
Interestingly, we also observed high expression of many
entries involved in vesicle mediated trans- or endocytosis.
For example, we found high expression of CAV1 and
CLTC in the CBE and we confirmed their presence by
immunohistochemistry (Figure 3). Caveolin and clathrin
are involved in vesicle mediated endo-, exo- and transcyto-
sis of large molecules through the cell [21-25]. Caveolin-
mediated vesicles transport for example iron, transferrin,
insulin, lipids, albumin, chemokines and pathogens [21].
Clathrin-mediated vesicles can transport nutrients, viruses,
toxins, plasma membrane proteins and signaling receptors,
including ß2-adrenergic receptors, CD4, insulin receptors,
T-cell and B-cell receptors [24,25]. While caveolin trans-
port is more or less a-specific, clathrin-mediated
vesicle transport is only possible with adaptor proteins (re-
ceptors). We also found expression of several genes coding
for other proteins involved in less specific vesicle trans-
port, like ANXA2, EXOC7, SORL1, STXBP3, SYT13,
VAT1, and VTI1B
In summary, our data, in combination with the lit-
erature, suggest that both general and specific vesicle
mediated transport play a role in the transport of a
range of biomolecules over the CBE neuroepithelia. In-
deed, this was already suggested by a histochemical
electron microscope study [26]. We hypothesize that
these transport mechanisms may (also) be involved in
AH composition, in particular with regard to the presence
of large molecules.
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In silico, we assigned several interacting proteins to the
extracellular space between the PE and NPE, where
transported molecules from the blood to the AH are
likely to pass. We found several proteins involved matrix
assembly and cytoskeleton organization, a network of
protease (inhibitors) and a group of proteins involved in
cell growth and proliferation pathways. These molecules
are likely to be involved in the local turnover of the ECM
between the PE-NPE layers of the CBE. We also identified
several entries within the PE-NPE apical extracellular
space of the CB that are involved in amyloid-beta me-
tabolism and plaque formation. The major transport
mechanisms to which these entries were connected were
vesicle-mediated transporters and lipid and xenobiotic
transporters. The molecules within the PE-NPE extracel-
lular space and their transporters may influence intrinsic
filtration or secretion capabilities of the CBE. If disrupted
by a genetic mutation, or altered by age-related oxidative
stress, these molecules change and may affect the AH
secretion and composition.
4. CBE transport and possible implications for POAG
We identified seven POAG candidate disease genes in our
Transport sub-dataset. These genes were APOE, CAV1,
COL8A2, EDNRA, FBN1, RFTN1 and TLR4. We hypothe-
sized that mutations in these genes might modify the AH
production and composition via the CBE. Although the
production rate of AH is hardly changed in POAG [27],
the composition of AH does, with overall an increase of
(large and harmful) proteins in POAG AH compared to
controls [5-7]. The POAG disease genes that we found in
our Transport sub-dataset code for structural components
(FBN1, COL8A2), transporters (CAV1, APOE, RFTN1)
and signaling molecules (CAV1, EDNRA), all potentially
involved in AH production and composition. Further
research is warranted to prove or reject their involvement
in disturbed AH dynamics of the CBE during POAG. It
would be of interest to study mouse models with muta-
tions in these genes, measure IOP, optic nerve head
characteristics and AH composition. It would also be
of interest to study the effect of IOP-lowering drugs in
animals with mutations in these target genes in compari-
son with controls.
5. Possible pharmacological targets for AH production
altering drugs within the CBE
Last but not least, we annotated our molecular model
(Figure 2, discussed above) with possible new therapeutic
targets that might alter AH production. First, we found sev-
eral drugs that block Na+/K +ATPases: digoxin, ethacrynic
acid, omeprazol, and perphenazine. Digoxin has antiar-
rhythmic effects via myocytes and some older literature
sources describe the lowering effect of digoxin on the IOPin human [28-30] and cats [31], probably due to blocking
of Na+/K+-ATPase in the CBE. Ethacrynic is a diuretic drug
and multiple animal studies already showed the IOP lower-
ing effect of intracameral or topical administered ethacrynic
acid in the eye, probably through increased AH outflow,
but possibly also by decreased AH production [32-39]. The
major disadvantage of athacrynic acid is the risk for (severe)
corneal edema. Omeprazole is a proton pump inhibitor that
inhibits gastric acid secretion in the stomach. In the litera-
ture, we found one clinical study in which treatment with
omeprazole indeed lowered the IOP [40]. The drug perphe-
nazine is an antagonist of dopamine receptors and has anti-
emetic and antipsychotic effects. We found no studies of
perhanzine in relation to IOP altering effects.
Secondly, we found one drug that block sodium channels,
namely riluzole. This drug is used in ALS. In the literature,
we couldn’t find studies describing an effect on IOP with
riluzole use.
Finally, we found several drugs that influence the activity
of potassium channels. Quinidine, amiodarone, tedisamil
and flecainide block potassium channels, while nicorandil
opens them. Only for the latter drug, nicorandil, two
studies exist on the IOP effects. Chiang and coworkers
[41] found increased IOPs after nicorandil use in rabbits,
whereas Chowdhury and coworkers [42] found an IOP
lowering effect of nicorandil in rats.
In conclusion, we found possible new therapeutic targets
for AH production modification in the CBE. These targets
are of interest, since IOP lowering is currently the only
proven therapy for POAG and current medical treatment
modalities often fail to reduce the IOP sufficiently. More
research into these new targets might result in new treat-
ment options for POAG, which may make surgery, with its
side effects and risks, less often needed. Extensive studies
in animal models are warranted to study potential benefi-
cial effects of these drugs on the IOP and their potential
harmful side effects.
Conclusions
The transport mechanisms in the CBE are numerous,
ranging from extensively studied specific ion channels
and pumps that form the basis of AH production, to
more generalized transport functions like vesicle medi-
ated transport. The CBE transports (neuro-) endocrine
and metabolic particles and is involved in specific apical
transport of ECM proteins and growth factors. Taken
together, these transport mechanisms are important in
determining the AH production rate and composition. In
POAG, the composition of the AH is changed and several
POAG disease gene are highly expressed, and their corre-
sponding proteins localized in the CBE plasma membrane
or extracellular space. We propose that mutations in these
POAG genes cause disturbances in the AH composition
by the CBE, resulting in a changed AH content and
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possible new therapeutic targets for AH production
modification in the CBE.
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